Sun Pharma share price

More Stories on Sun Pharma share price

SPARC shares zoom 34% in two days on favourable US court ruling

Dec 03, 2025, 10:07 AM IST

"We are pleased with the ruling issued by the US District Court, as it validates SPARC's long held position on this matter," SPARC CEO Anil Raghavan said in the statement.

Sun Pharma Advanced shares hit 20% upper circuit level; here's why

Dec 02, 2025, 01:14 PM IST

SPARC: The stock jumped 20 per cent to touch its upper price band of Rs 161.10, although it remains down 19.73 per cent on a year-to-date (YTD) basis.

Sun Pharma shares in focus as NCLT clears merger of subsidiaries; details here

Oct 09, 2025, 08:57 AM IST

On Wednesday, Sun Pharma stock declined 1.37 per cent to settle at Rs 1,631.65. The company commands a market capitalisation of Rs 3.91 lakh crore.

Target prices for Sun Pharma, Lupin, Dr Reddy's, Zydus Life, Cipla: Q2 preview

Oct 08, 2025, 11:04 AM IST

The brokerage has maintained a ‘Positive’ sector view, forecasting EBITDA margins to remain “broadly stable” as companies focus on improving their product mix.

Pharma tariff: Aurobindo, Lupin, DRL, Sun, Zydus, Biocon in focus after 100% Trump tariff

Sep 26, 2025, 07:51 AM IST

Trump tariff: US exports as percentage of Biocon's sales stands at 46 per cent. Cipla (29 per cent), Dr Reddy's Labs (46 p cent), Lupin (36 per cent) and Sun Pharma (33 per cent), are other pharma exporters to the US.

Sun Pharma: What JM Financial says as Halol plant gets OAI tag; check key stock drivers

Sep 10, 2025, 11:02 AM IST

On Wednesday, Sun Pharma stock fell as much as 0.95 per cent to hit the day’s low of Rs 1,580.05 apiece on the BSE, over its previous close of Rs 1,595.10.

Sun Pharma tanks 6% on weak Q1; Choice sees 11% upside; here’s target price

Aug 01, 2025, 11:47 AM IST

Choice Broking maintained an ‘ADD’ rating and a target price of Rs 1,825 on Sun Pharma. At the prevailing price, the target suggests 11 per cent potential upside.

SPARC shares slump 20%, Sun Pharma also declines amid failed drug trials

Jun 04, 2025, 10:35 AM IST

Sun Pharma's shares experienced a 0.47 per cent decline, trading at Rs 1,659.80, alongside the sharper fall in SPARC shares to Rs 156.50 on the BSE.

Pharma stocks unfazed as US Trump admin launches probe into imported drugs

Apr 16, 2025, 09:55 AM IST

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in the US, as per some estimates.

Aurobindo, Sun Pharma, other pharma stocks in focus after 90-day Trump tariff pause

Apr 10, 2025, 10:02 AM IST

Aurobindo Pharma and Gland Pharma have fallen 9 per cent each in the past one week and 22-23 per cent in 2025 so far. Glenmark Pharma is down 9 per cent for the week month period and 14 per cent year-to-date.

Pharma stocks crack up to 10% as Trump warns of 'never seen before' tariffs

Apr 04, 2025, 12:01 PM IST

Granules India, Lupin, Gland Pharma and Cipla fell 5-6 per cent. Sun Pharmaceutical Industries slipped 5 per cent while Dr Reddy's Labs was down 4 per cent.